AHA
Content about the ºÚÁÏÕýÄÜÁ¿ Association, its business units and its activities.
A new AHA issue brief offers a prototype practice model to help hospitals and health systems meet the complex needs of older adults across care settings.
The AHA today submitted comments on the Food and Drug Administration’s Medical Device Safety Action Plan.
The AHA today named as its senior vice president for field engagement C. Douglas Shaw, currently chief operating and development officer for the association’s Health Forum subsidiary.
AHA supports the Senate Health, Education, Labor and Pensions Committee’s bipartisan reauthorization of the hospital and public health preparedness programs contained within S. 2852, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.
The AHA today expressed support for the Opioid Workforce Treatment Act of 2018 (H.R. 5818/S. 2843), bipartisan, bicameral legislation that would reduce the shortage of opioid treatment providers by increasing the number of Medicare-funded residency slots in hospitals with programs focused on…
AHA today urged the Health Resources and Services Administration to implement without further delay its final regulation on 340B drug ceiling prices and civil monetary penalties for manufacturers.
The Institute for Healthcare Improvement today convened a national steering committee, whose members include the AHA, to create a national plan to accelerate patient safety progress across the care continuum.
The House Energy and Commerce Committee yesterday approved 32 bills to address the opioid crisis, including 12 AHA-supported bills.
The 19th Annual Not-for-Profit Health Care Investor Conference kicks off today in New York City, providing an important opportunity for not-for-profit health systems to maintain a dialogue with investors.
The AHA and seven other national hospital organizations yesterday voiced strong support for legislation that would allow states to receive federal matching funds for services provided to a Medicaid beneficiary with a substance use disorder in an Institution for Mental Disease.